Kentucky Retirement Systems Insurance Trust Fund purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 5,384 shares of the company's stock, valued at approximately $1,860,000.
Several other large investors also recently made changes to their positions in HCA. Atwood & Palmer Inc. acquired a new position in shares of HCA Healthcare during the first quarter worth about $28,000. Whipplewood Advisors LLC bought a new stake in HCA Healthcare during the 4th quarter worth about $31,000. ORG Partners LLC raised its holdings in HCA Healthcare by 344.0% during the first quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after acquiring an additional 86 shares in the last quarter. Tidemark LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth approximately $36,000. Finally, Legacy Investment Solutions LLC grew its stake in shares of HCA Healthcare by 99.0% in the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock valued at $62,000 after buying an additional 95 shares in the last quarter. Institutional investors own 62.73% of the company's stock.
Wall Street Analysts Forecast Growth
HCA has been the subject of several recent analyst reports. Barclays set a $416.00 target price on shares of HCA Healthcare and gave the company an "overweight" rating in a research note on Monday, June 2nd. Wells Fargo & Company upgraded HCA Healthcare from an "underweight" rating to an "equal weight" rating and increased their price target for the company from $320.00 to $385.00 in a research note on Thursday, May 29th. Robert W. Baird restated a "neutral" rating and set a $336.00 target price (down previously from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Guggenheim initiated coverage on shares of HCA Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating on the stock. Finally, Royal Bank Of Canada increased their target price on shares of HCA Healthcare from $376.00 to $404.00 and gave the stock an "outperform" rating in a research report on Monday. Seven research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $394.33.
Get Our Latest Report on HCA
Insider Transactions at HCA Healthcare
In other news, COO Jon M. Foster sold 15,698 shares of the business's stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the sale, the chief operating officer now owns 12,646 shares in the company, valued at $4,670,420.72. The trade was a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 1.30% of the company's stock.
HCA Healthcare Trading Up 0.1%
Shares of HCA Healthcare stock traded up $0.34 on Tuesday, hitting $379.06. The stock had a trading volume of 1,103,292 shares, compared to its average volume of 1,469,725. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 1.06 and a current ratio of 1.19. The firm has a market capitalization of $91.19 billion, a P/E ratio of 16.85, a PEG ratio of 1.31 and a beta of 1.49. The stock has a 50 day moving average of $363.06 and a 200 day moving average of $335.36.
HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.75 by $0.70. The business had revenue of $18.32 billion during the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. HCA Healthcare's revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period last year, the company earned $5.36 EPS. Sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.
HCA Healthcare Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be paid a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.76%. HCA Healthcare's dividend payout ratio is currently 12.81%.
HCA Healthcare Company Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
See Also

Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.